Clinical improvement by tiotropium plus olodaterol

In this study, patients were allowed to continue their inhaled corticosteroid (ICS) therapy, and 34.8–41.9% of patients had ICS in each group of the patients.
Source: Respiratory Medicine CME - Category: Respiratory Medicine Authors: Tags: Correspondence Source Type: research